Carl L. Heifetz
- Molecular Biology
- Organic Chemistry top 5%
- Pharmacology top 5%
- Molecular Medicine top 2%
- Epidemiology
- Co-authors
- John M. DomagalaJoseph P. SanchezMarland P. HuttT. F. MICHMarjorie S. SolomonSusan E. HagenJ. M. DOMAGALAMichael Cohen
- Topics
- Antibiotics Pharmacokinetics and Efficacy (19 papers)Cancer therapeutics and mechanisms (16 papers)Antibiotic Resistance in Bacteria (10 papers)
- Journals
- Journal of Clinical MicrobiologyJournal of Medicinal ChemistryAntimicrobial Agents and Chemotherapy
- Partner nations
- United States
In The Last Decade
Carl L. Heifetz
32 papers receiving 691 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 412
- Organic Chemistry 341
- Pharmacology 312
- Molecular Medicine 198
- Epidemiology 98
Countries citing papers authored by Carl L. Heifetz
This map shows the geographic impact of Carl L. Heifetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl L. Heifetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl L. Heifetz more than expected).
Fields of papers citing papers by Carl L. Heifetz
This network shows the impact of papers produced by Carl L. Heifetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl L. Heifetz. The network helps show where Carl L. Heifetz may publish in the future.
Co-authorship network of co-authors of Carl L. Heifetz
This figure shows the co-authorship network connecting the top 25 collaborators of Carl L. Heifetz. A scholar is included among the top collaborators of Carl L. Heifetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl L. Heifetz. Carl L. Heifetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 17 | |
| 4 | 1 | |
| 5 | 20 | |
| 6 | 27 | |
| 7 | 27 | |
| 8 | 29 | |
| 9 | 12 | |
| 10 | 28 | |
| 11 | 26 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 77 | |
| 15 | 108 | |
| 16 | 24 | |
| 17 | 5 | |
| 18 | 5 | |
| 19 | 6 | |
| 20 | 2 |
About Carl L. Heifetz
Carl L. Heifetz is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 35 papers that have together received 802 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Cancer therapeutics and mechanisms (16 papers) and Antibiotic Resistance in Bacteria (10 papers). The work is most often cited by research in Molecular Medicine (198 citations), Pharmacology (312 citations) and Toxicology (49 citations). Carl L. Heifetz has collaborated with scholars based in United States. Frequent co-authors include John M. Domagala, Joseph P. Sanchez, Marland P. Hutt, T. F. MICH, Marjorie S. Solomon, Susan E. Hagen, J. M. DOMAGALA, Michael Cohen, Ashok K. Trehan and Martin A. Shapiro. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.